This resource was developed by AHRQ as part of its Public Health Emergency Preparedness program, which was discontinued on June 30, 2011. Many of AHRQ's PHEP materials and activities will be supported by other Federal agencies. Notice of transfer to another agency will be posted on this site.
This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Table 11. Data Availability for Schedule II Controlled Substances
Data
Availability
|
Schedule II Controlled Substances Data
|
Advantage
|
Disadvantage
|
Public use files
|
SAMHDA
|
-
Counts patients
receiving methadone or buprenorphine as inpatients, outpatients, and
residential.
- Data from 2005.
|
|
CMS approval/ DUA required
|
Medicare claims
|
-
Captures the use of Schedule
II controlled substances by persons living in the Worcester zip code.
|
-
Data are limited to
a segment of the population that is older than 65, has a disability, or has ESRD.
|
Medicaid claims
|
-
Captures the use of Schedule
II controlled substances by persons living in the Worcester zip code.
|
-
Data are limited to
low-income individuals, which varies from State to State and year to year.
|
Return to Document